Static hyperinflation is associated with decreased peak exercise performance in children with cystic fibrosis

Respiratory Care

Volumn 58, Issue 2, 2013, Pages 291-297

  Sovtic, Aleksandar D ^a   Minic, Predrag B ^a   Kosutic, Jovan ^a,c   Markovic Sovtic, Gordana P ^a   Gajic, Milan B ^b,c  

^a Mother and Child Health Institute Belgrade rs   (Serbia)

^b Institute for Medical Statistics   (Serbia)

^c UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Blood gas analysis; Cystic fibrosis; Exercise test; Spirometry; Whole body plethysmography

Indexed keywords

ADOLESCENT; ARTICLE; BREATHING EXERCISE; BREATHING RATE; CARDIOPULMONARY EXERCISE TEST; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FEMALE; FORCED EXPIRATORY VOLUME; FUNCTIONAL ASSESSMENT; HUMAN; HYPERINFLATION; HYPOXEMIA; LUNG CAPACITY; LUNG FUNCTION TEST; MALE; OUTCOME ASSESSMENT; OXYGEN CONSUMPTION; OXYGEN SATURATION; PHYSICAL ACTIVITY; PREDICTION; RISK FACTOR; SCHOOL CHILD;

ADOLESCENT; ANOXIA; BLOOD GAS ANALYSIS; CHILD; CYSTIC FIBROSIS; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; OXYGEN CONSUMPTION; PEROXIDES; PLETHYSMOGRAPHY; PULMONARY VENTILATION; RESIDUAL VOLUME; SPIROMETRY; TOTAL LUNG CAPACITY; UREA;

EID: 84873672861     PISSN: 00201324     EISSN: 19433654     Source Type: Journal    
DOI: 10.4187/respcare.01946     Document Type: Article

References (36)

1. Paranjape SM, Barnes LA, Carson KA, von Berg K, Loosen H, Mogayzel PJ. Exercise improves lung function and habitual activity in children with cystic fibrosis. J Cyst Fibros 2012;11(1):18-23.
2. Hind K, Truscott JG, Conway SP. Exercise during childhood and adolescence: a prophylaxis against cystic fibrosis-related low bone mineral density? Exercise for bone health in children with cystic fibrosis. J Cyst Fibros 2008;7(4):270-276.
3. Moorcroft AJ, Dodd ME, Webb AK. Exercise limitations and training for patients with cystic fibrosis. Disabil Rehabil 1998;20(6-7): 247-253.
4. Troosters T, Langer D, Vrijsen B, Segers J, Wouters K, Janssens W, et al. Skeletal muscle weakness, exercise tolerance and physical activity in adults with cystic fibrosis. Eur Respir J 2009;33(1):99-106.
5. Marcotte JE, Grisdale RK, Levison H, Coates AL, Canny GJ. Multiple factors limit exercise capacity in cystic fibrosis. Pediatr Pulmonol 1986;2(5):274-281.
6. Marcotte JE, Canny GJ, Grisdale R, Desmond K, Corey M, Zinman R, et al. Effect of nutritional status on exercise performance in advanced cystic fibrosis. Chest 1986;90(3):375-379.
7. Pianosi P, LeBlanc J, Almudevar A. Relationship between FEV1 and peak oxygen uptake in children with cystic fibrosis. Pediatr Pulmonol 2005;40(4):324-329.
8. Nixon PA, Orenstein DM, Kelsey SF, Doershuk CF. The prognostic value of exercise testing in patients with cystic fibrosis. N Engl J Med 1992;327(25):1785-1788.
9. Moorcroft AJ, Dodd ME, Webb AK. Exercise testing and prognosis in adult cystic fibrosis. Thorax 1997;52(3):291-293.
10. Pianosi P, LeBlanc J, Almudevar A. Peak oxygen uptake and mortality in children with cystic fibrosis. Thorax 2005;60(1):50-54.
11. Werkman MS, Hulzebos HJ, Arets HG, van der Net J, Helders PJ, Takken T. Is static hyperinflation a limiting factor during exercise in adolescents with cystic fibrosis. Pediatr Pulmonol 2011;46(2): 119-124.
12. Sexauer WP, Cheng HK, Fiel SB. Utility of the breathing reserve index at the anaerobic threshold in determing ventilatory-limited exercise in adult cystic fibrosis. Chest 2003;124(4):1469-1475.
13. McKone EF, Barry SC, Fitzgerald MX, Gallagher CG. Role of arterial hypoxemia and pulmonary mechanics in exercise limitation in adults with cystic fibrosis. J Appl Physiol 2005;99(3):1012-1018.
14. Rosenstein BJ, Cutting GR. The diagnosis of cystic fibrosis: a consensus statement. Cystic Fibrosis Foundation consensus panel. J Pediatr 1998;132(4):589-595.
15. Dodd JD, Barry SC, Daly LE, Gallagher CG. Inhaled beta-agonists improve lung function but not maximal exercise capacity in cystic fibrosis. J Cyst Fibros 2005;4(2):101-105.
16. Serisier DJ, Coates AD, Bowler SD. Effect of albuterol on maximal exercise capacity in cystic fibrosis. Chest 2007;131(4):1181-1187.
17. Tegtmeyer K, Brady G, Lai S, Hodo R, Braner D. Placement of an arterial line. N Engl J Med 2006;354(15):e13.
18. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al; ATS/ERS Task Force. Standardization of spirometry. Eur Respir J 2005;26(2):319-338.
19. Gibson G. Tests of mechanical function. In: Clinical tests of pulmonary function. London: Chapman & Hall; 1996:13-53.
20. Zapletal A, Samanek M, Paul T. Lung function in children and adolescents: methods, reference values. In: Zapletal A, editor. Progress in respiration research, Vol. 22. Basel: Karger; 1987:114-118.
21. Kraemer R, Blum A, Schilber A, Ammann R, Gallati S. Ventilation inhomogeneities in relation to standard lung function in patients with cystic fibrosis. Am J Respir Crit Care Med 2005;171(4):371-378.
22. Beardsmore C. Lung function from infancy to school age in cystic fibrosis. Arch Dis Child 1995;73:519-523.
23. Nikolaizik WH, Knopfli B, Leister E, de Boer P, Sievers B, Schoni MH. The anaerobic threshold in cystic fibrosis: comparison of Vslope method, lactate turn points, and Conconi test. Pediatr Pulmonol 1998;25(3):147-153.
24. Gibson GJ. Pulmonary hyperinflation a clinical overview. Eur Respir J 1996;9(6):2640-2649.
25. Alison JA, Regnis JA, Donnelly PM, Adams RD, Sullivan CE, Bye PT. End-expiratory lung volume during arm and leg exercise in normal subjects and patients with cystic fibrosis. Am J Respir Crit Care Med 1998;158(5):1450-1456.
26. De Troyer A. Effect of hyperinflation on the diaphragm. Eur Respir J 1997;10(3):708-713.
27. Vogiatzis I, Georgiadou O, Golemati S, Aliverti A, Kosmas E, Kastanakis E, et al. Patterns of dynamic hyperinflation during exercise and recovery in patients with severe chronic obstructive pulmonary disease. Thorax 2005;60(9):723-729.
28. Wilkens H, Weingard B, Lo Mauro A, Schena E, Pedotti A, Sybrecht GW, Aliverti A. Breathing pattern and chest wall volumes during exercise in patients with cystic fibrosis, pulmonary fibrosis and COPD before and after lung transplantation. Thorax 2010;65(9):808-814.
29. Caviedes IR, Delgado I, Soto R. Ventilatory inefficiency as a limiting factor for exercise in patients with COPD. Respir Care 2012; 57(4):583-589.
30. Godfrey S, Mearns M. Pulmonary function and response to exercise in cystic fibrosis. Arch Dis Child 1971;46(246):144-151.
31. Wasserman K, Hansen J, Sue D, Stringer W, Whipp B. Pathophysiology of disorders limiting exercise. In: Principles of exercise testing and interpretation. Philadelphia: Lippincott Williams & Wilkins; 2005:120-123.
32. Moorcroft AJ, Dodd ME, Morris J, Webb AK. Symptoms, lactate and exercise limitation at peak cycle ergometry in adults with cystic fibrosis. Eur Respir J 2005;25(6):1050-1056.
33. Klijn PH, van der Net, Kimpen JL, Helders PJ, van der Ent CK. Longitudinal determinants of peak aerobic performance in children with cystic fibrosis. Chest 2003;124(6):2215-2219.
34. Gruet M, Brisswalter J, Mely L, Vallier JM. Clinical utility of the oxygen uptake efficiency slope in cystic fibrosis patients. J Cyst Fibros 2010;9(5):307-313.
35. Elphick HE, Mallory G. Oxygen therapy for cystic fibrosis. Cochrane Database Syst Rev 2009;(1):CD003884. DOI: 10.1002/14651858. CD003884.pub3.
36. Urguhart DS, Mongomery H, Jaffe A. Assessment of hypoxia in children with cystic fibrosis. Arch Dis Child 2005;90(11):1138-1143.